Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3689d-1 (MIR3689D1) is a human microRNA gene encoding a small, single-stranded non-coding RNA molecule ~20–24 nucleotides long. MicroRNAs are evolutionarily conserved regulators of gene expression, typically acting at the post-transcriptional level to reduce the translation or stability of target mRNA transcripts. The biogenesis pathway of microRNAs includes the formation of a primary transcript (pri-miRNA), cleavage by the Drosha-DGCR8 microprocessor, nuclear export, cleavage by Dicer, and incorporation into the Argonaute (AGO) complex forming the miRNA-induced silencing complex (miRISC). Mature miRISC binds to partially complementary sites in the untranslated regions (primarily 3'UTRs) of messenger RNAs, usually resulting in translational inhibition or mRNA destabilization[1][2][3][4]. At present, there are no published gene targets, disease associations, or known mechanistic roles specific to microRNA 3689d-1. It is one of many human microRNAs cataloged based on sequence; its biological and clinical significance remains to be experimentally elucidated[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3689d-1 (MIR3689D1).